DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.79−0.54 (-5.79%)
Close on Nov 13, 2026Market cap $474.01MP/E –Yield –
DiaMedica Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
DiaMedica Therapeutics's operating cash flow for the twelve months ending Sep 30, 2026 was -$33.79M. For fiscal 2025 it was -$29.06M. The highest annual figure on record is -$3.90M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.06M | – |
| FY2024 | Dec 31, 2024 | -$22.08M | – |
| FY2023 | Dec 31, 2023 | -$18.73M | – |
| FY2022 | Dec 31, 2022 | -$11.51M | – |
| FY2021 | Dec 31, 2021 | -$12.25M | – |
| FY2020 | Dec 31, 2020 | -$9.19M | – |
| FY2019 | Dec 31, 2019 | -$9.10M | – |
| FY2018 | Dec 31, 2018 | -$5.70M | – |
| FY2017 | Dec 31, 2017 | -$3.90M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$8.83M | – |
| Q2 FY2026 | Jun 30, 2026 | -$8.11M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.08M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.55M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.60M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.15M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.43M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.47M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.52M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.65M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.81M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.80M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.03M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.09M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.77M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.36M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.50M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.89M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.80M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.05M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.09M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.31M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.02M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.35M | – |
| Q2 FY2020 | Jun 30, 2020 | -$844.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.98M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.87M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.23M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.87M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.13M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.90M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.84M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.02M | – |
| Q1 FY2018 | Mar 31, 2018 | -$935.00K | – |
See a number that looks wrong?